Comparative review of analytical techniques for determination of carbapenems

Current Analytical Chemistry

Volumn 8, Issue 1, 2012, Pages 91-115

  Cielecka Piontek, Judyta ^a   Michalska, Katarzyna ^b   Zalewski, Przemysław ^a   Zasada, Stefan ^c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Analytical methods; Biapenem; Doripenem; Ertapenem; Imipenem; Meropenem; Panipenem; Validation

Indexed keywords

ANTIBIOTICS; CAPILLARY ELECTROPHORESIS; DEGRADATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANALYTICAL METHOD; BIAPENEM; CARBAPENEMS; DEGRADATION PRODUCTS; DORIPENEM; ERTAPENEM; IMIPENEM; MEROPENEM; PANIPENEM; VALIDATION;

SPECTROPHOTOMETRY;

EID: 84855281407     PISSN: 15734110     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341112798472206     Document Type: Review

References (151)

1. Bonfiglio, G.; Russo, G.; Nicoletti, G. Recent developments in carbapenems. Expert Opin. Investig. Drugs, 2002, 11, 529-544.
2. Norrby, S. Carbapenems. Med. Clin. North Am., 1995, 79, 745-759.
3. Goa, K.; Noble S. Panipenem/Betamipron. Drugs, 2003, 63, 913-925.
4. Hurt, M.; Lamb, H. Meropenem:a review of its use in patients in intensive care. Drugs, 2000, 59, 653-680.
5. Curran, M.; Simpson, D.; Perry C. Ertapenem: a review of its use in the management of bacterial infections. Drugs, 2003, 63, 1855-1878.
6. Perry, C.; Ibbotson, T. Biapenem. Drugs, 2002, 62, 221-2234.
7. Walsh, F. Doripenem: a new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities. Ther. Clin. Risk Manag., 2007, 3, 789-794.
8. Zhanel, G.; Wiebe, R.; Dialy, L.; Thomsaon, K.; Rubistein, E.; Hoban, D.; Noreddin, A.; Karlowsky, J. Comparative review of the carbapenems. Drugs, 2007, 67, 1027-1052.
9. Kato, K.; Shirasaka, Y.; Kuraoka, E.; Kikuchi, A.; Iguchi, M.; Suzuki, H.; Shibasaki, S.; Kurosawa, T.; Tamai, I. Intestinal absorption mechanism of tebipenempivoxil a novel oral carbapenem: involvement of human OATP family in apical membrane transport. Mol. Pharmaceut., 2010, 7, 1747-1756.
10. Coulton, S.; Hunt, E. Recent advances in the chemistry and biology of carbapenems antibiotics. In: Progress in Medicinal Chemistry, Elservier Science BV, 1996; pp. 93-100.
11. Sader, H.; Gales, A. Emerging strategies in infectious diseases. Drugs, 2001, 61, 553-564.
12. Edwards, J.; Bett, M. Carbapenems: the pinnacle of the β-lactam antibiotics or room for improvement. J. Antimicrob. Chemother., 2000, 45, 1-4.
13. Edwards, S.; Emmas, C.; Campbell, H. Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections. Curr. Med. Res. Opin., 2005, 21, 785-794.
14. Ratcliffe, R.W.; Wildonger, L.D.; Michele, L.D.; Douglas, A.W.; Hajdu, R.; Goegelman, R.T.; Springer, J.P.; Hirsfield, J. Studies on the structures of imipenem, dehyrodpeptidase I-hydrolyzed imipenem, and related drugs. J. Org. Chem., 1989, 54, 653-660.
15. Fish, D.; Teitelbaum, I.; Abraham, E. Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically III patiens. Antimicrob. Agents Chemother., 2005, 49, 2421-2428.
16. Meyers, C.; Blumer, J. Determination of imipenem and cilastatin in serum by high-pressure liquid chromatography. Antimicrob. Agents Chemother., 1984, 26, 78-81.
17. Freij, B.; McCracken, G.; Olsen, K.; Threlkeld, N. Pharmacokinetics of imipenem-cilastatin in neonates. Antimicrob. Agents Chemother., 1985, 27, 431-435.
18. Krausse, R.; Ullmann, U. Determination of imipenem and cilastatin in serum and tissue by high-pressure liquid chromatography. Infection, 1986, 5, 243-245.
19. Garcia-Capdevila, L.; Lopez-Callul, C.; Arroyo, C.; Moral, M.; Mangues, M.; Bonal, J. Determination of imipenem by highperformance liquid chromatography for pharmacokinetics studies in patients. J. Chromatogr. B, 1997, 692, 127-132.
20. Swanson, D.; DeAngelis, C.; Smith, I.; Schentag, J.J. Degradation kinetics of imipenem in normal saline and human serum. Antimicrob. Agents Chemother., 1986, 29, 936-937.
21. Boulamery, A.; Kadra, G.; Simon, N.; Besnard, T.; Bruguerolle, B. Chronopharmacokinetics of imipenem in the rat. Chronobiol. Inter., 2007, 24, 961-968.
22. Musson, D.; Hajdu, R.; Bayne, W.; Rogers, J.; Quantification of imipenem's primary metabolite in plasma by postcolumn chemical rearrangement and UV detection. Pharm. Res., 1991, 8, 33-39.
23. Xu, Y.; Xie, W.; Miller-Stein, C.; Woolf, E. Hydrophilic interaction chromatography/tendem mass spectrometry for the simultaneous determination of three polar non-strucurally related compounds, imipenem, cilastatin and an investigational β-lactamase inhibitor, MK-4698, in biological matrices. Rapid Commun. Mass Spectrom., 2009, 23, 2195-2205.
24. Monograph of imipenem. In: European Pharmacopoeia, 7th ed., 2010; pp. 2230-2231.
25. Monograph of imipenem. In: U.S. Pharmacopeia, 32nd ed.; USA 2008, pp. 2616-2617.
26. Monograph of imipenem and cilastatin for injection. In: U.S. Pharmacopeia, 32nd ed.; USA 2008, pp. 2617-2619.
27. Monograph of imipenem. In: British Pharmacopoeia 2009, 2009.
28. Monograph of imipenem, In: Japan Pharmacopoeia XIV, 2001, pp. 530.
29. Smith, G.B.; Dezeny, G.; Douglas, A. Stability and kinetics of degradation of imipenem in aqueous solution. J. Pharm. Sci., 1990, 79, 732-740.
30. Mendez, R.; Alemany, T.; Martin-Villacort, J. Catalytic effect of buffers on degradation of imipenem (N-formimidoylthienamycin) in aqueous solution. Chem. Pharm. Bull., 1991, 39, 831-835.
31. Mendez, R.; Alemany, T.; Martin-Villacort, J. Catalysis of hydrolysis and aminolysis of non-classical β-lactam antibiotics by metal ions and metal chelates. Chem. Pharm. Bull., 1992, 40, 3228-3233.
32. Trissel, L.; Quanyun, B. Stability of imipenem-cilastatin sodium in autodose infusion system bags. Hosp. Pharm., 2003, 38, 130-134.
33. Connolly, M.; Debenedetti, P.G.; Tung, H. Freeze crystallization of imipenem. J. Pharm. Sci., 1996, 85, 174-177.
34. Chaudhary, A.K.; Waske, S.A.; Yaadav, S.; Chandrashekhar, G.; Singh, V. Validated reverse phase HPLC method for the deremination of DEHP content in reconstituting diluents an in reconstituted solutions of imipenem and cilastatin for injection. E-J. Chem., 2010, 7, 501-513.
35. Sun, C.; Wu, J.; Pan, Y. Charaterization of novel hydrolysis products of carbapenems by electrospray ionization mass spectrometry. Rapid Common. Mass Spectrom., 2009, 23, 3205-3212.
36. Abdel-Moety, E.; Elragehy, N.; Hassan, N.; Rezk, M. Selective determination of ertapenem and imipenem in the presence of their degradants. J. Chrom. Sci., 2010, 48, 624-630.
37. Forsyth, R.; Ip, D. Determination of imipenem and cilastatin sodium in Primaxin® by first order derivative ultraviolet spectrophotometry. J. Pharm. Biomed. Anal.,1994, 12, 1243-1248
38. Fernandez-Torres, R.; Navarro, M.; Lopez, B.; Mochon, M.; Sanchez, J. Urea as new stabilizing agent for imipenem determination. Electrochemical study and determination of imipenem and its primary metabolite in human urine. Talanta, 2008, 77, 241-248.
39. Hilali, A.; Jiménez, J.C.; Callejón, M.; Bello, M.A.; Guiraúm, A.; Electrochemical study of imipenem's primary metabolite at the mercury electrode. Voltammetric determination in urine. J. Pharm. Biomed. Anal., 2005, 38, 768-775.
40. Watanabe, A.; Tokue, Y.; Takahashi, H. Comparative in vitro activity of carbapenem antibiotics against respiratory pathologens isolated between 1999 and 2000. J. Infect. Chemother., 2001, 48, 723-271.
41. Kokubun, H.; Kimura, T.; Murase, S.; Shimada, S.; Kubo, H.; Matsumaoto, M.; Nowatari, M.; Matsuura, N. Determination of panipenem in neonatal plasma by HPLC. Anal. Sci., 2000, 16, 1077-1078.
42. Kimura, T.; Kokubun, H.; Nowatari, M.; Matsuura, N.; Sunakawa, K.; Kubo, H. Polutation pharmacokinetics of panipenem in neonates and retrosapective evaluation of dosage. J. Antimicrob. Chemother., 2001, 47, 51-59.
43. Ohashi, N.; Uematsu, T.; Nagashima, S.; Kanamaru, M.; Tajima, N.; Togawa, A.; Hishida, A. Pharmacokinetics of panipenem/betamipron in patients with end-stage renal disease. J. Infect. Chemother., 2005, 11, 24-31.
44. Tajima, N.; Ishizuka, H.; Naganuma, H. Population pharmacokinetic analysis of panipenem/betamipron in patients with various degrees of renal function. Chemotherapy, 2006, 52, 245-253.
45. Hisaoka, M.; Naganuma, M.; Yamazaki, Y.; Takahagi, H.; Kawahara, Y. High-performance liquid chromatography (HPLC) for determination of panipenem/betamipron concentration in body fluids. Chemotherapy, 1991, 39, 197-205.
46. Kojima, S.; Nadai, M.; Kitaichi, K.; Wang, L.; Toshitaka, N.; Hasegawa, T. Possible Mechanism by which the carbapenem antibiotic panipenemdecreseases the concentration of valproic acid in plasma rats. Antimicrob. Agents Chemother., 1998, 432, 3136-3140.
47. Monograph of panipenem. In: Japan Pharmacopoeia XIV, 2001, pp. 667-669.
48. Ito, N.; Suzuki, M.; Kusai, A.; Takayama, K. Isomerization kinetics of panipenem in aqueous solution. Chem. Pharm. Bull., 2005, 53, 537-540.
49. Ito, N.; Suzuki, M.; Kusai, A.; Takayama, K. Effect of initial concentration on stability of panipenem in aqueous solution. Chem. Pharm. Bull., 2005, 53, 323-327.
50. Lowe, M.N.; Lamb, H.M. Meropenem, an updated review of its use in the management of intra-abdominal infections. Drugs, 2000, 60, 619-646.
51. Monograph of Meropenem trihydrate. In: European Pharmacopoeia, 7th ed., 2010; pp. 2450-2451.
52. Ozkan, Y.; Kucukguzel, I.; Ozkan, S.; Aboul-Enein, H. A rapid, sensitive high performance liquid chromatographic method for the determination of meropenem in pharmaceutical dosage form, human serum and urine. Biomed. Chrom., 2001, 15, 263-266.
53. Ikeda, K.; Ikawa, K.; Morikawa, N.; Miki, M.; Nishimura, Sh.; Kobayashi, M. High-performance liquid chromatography with ultrafiolet detection for real-time therapeutic drug monitoring of meropnem in plasma. J. Chromatogr. B., 2007, 856, 371-375.
54. Robatel, C.; Buclin, T.; Eckert, P.; Schaller, M.D.; Biollaz, J.; Decostered, L.A. Determination of meropenem in plasma and filtrate- dialysate from patients under continousveno-venous haemodiafiltration by SPE-LC. J. Pharm. Biomed. Anal., 2002, 29, 17-33.
55. Farin, D.; Kitzes-Cohen, R.; Piva, G.; Gozlan, I. High performance iquid chromatography method for the determination of meropenem in human plasma. Chromatographia, 1999, 49, 253-255.
56. Matsudo, T.; Ikawa, K.; Ikeda, K.; Morikawa, N.; Tsumura, R.; Shibukawa, M.; Lida, K.; Kurisu, K. LC method for the determination of meropenem in cerebraspinal fluid: application to therapeutic drug monitoring. Chromatographia, 2009, 69, 1031-1034.
57. Chang, Y.L.; Chou, M.H.; Lin, M.F.; Chen, C.F.; Tsai, T.H. Determination and pharmacokinetic study of meropenem in rate bile using on-line microdialysis and liquid chromatography. J. Chromatogr. A, 2002, 961, 119-124.
58. Bompadre, S.; Ferrante, L.; Martinis, M.; Leone, L. Determination of meropenem in serum by high-performace liquid chromatography with column switching. J. Chromatogr. A., 1998, 812, 249-253.
59. Schauerberger, J.; Amon, M.; Wedrich, A.; Nepp, J.; Menyawi, I.E.; Derbolaw, A.; Graninger, W. Penetration and decay of meropenem into the human aqueous humor and vitreous. J. Ocular Pharm. Therap., 1999, 15, 439-445.
60. Kipper, K.; Anier, K.; Leito, I.; Karjagin, J.; Oselin, K.; Herodes, K. Rapid determination of meropenem in biological fluids by LC: comparison of various methods for samples preparation and investigation of meropenem stability. Chromatographia, 2009, 70, 142-1427.
61. Thalhammer, F.; Schenk, P.; Burgmann, H.; Menyawi, I.; Hollenstein, U.; Rosenkranz, A.; Sunder-Plassmann, G.; Breyer, S.; Ratheiser, K. Single-dose pharmacokinetics of meropenem during continousvenovenous hemofiltration. Antimicrob. Agents Chemother., 1998, 42, 2417-2420.
62. Roberts, J.; Kirkpatrick, C.; Roberts, M.; Robertson, T.; Dalley, A.; Lipman, J. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. J. Antimicrob. Chemother., 2009, 64, 142-150.
63. Don, K.; Woo, H.; Hur, J.; Yim, H.; Kim, J.; Chae, H.; Seunghoon, H.; Yim, D. Population pharmacokinetics of meropenem in burn patients. J. Antimicrob. Chemother., 2010, 65, 2428-2435.
64. Jaruratanasirikul, S.; Sriwiriayajan, S. Comparison of the pharmacodynamics of meropenem in healthy volunteers following administration by intermittent infusion or bolus injection. J. Antimicrob. Chemother., 2003, 52, 519-521.
65. Allegranzi, B.; Cazzadori, A.; Perri, G.; Bonora, S.; Berti, M.; Franchino, L.; Biglino, A.; Cipriani, A.; Concia E. Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lininf fluid. J. Antimicrob. Chemother., 2000, 46, 319-322.
66. Monograph of Meropenem trihydrate. In: Japan Pharmacopoeia XIV, 2001, pp. 605-606.
67. Monograph of Meropenem. In: U.S. Pharmacopeia, 32, ed.; 2008, pp. 2891-2892.
68. Monograph of Meropenem for injection. In: U.S. Pharmacopeia, 32, ed.; 2008, pp. 2892-2893.
69. Mendez, A.S.; Steppe, M.; Schapoval, E.E. Validation of HPLC and UV spectrophotometric methods for the determination of meropenem n pharmaceutical dosage form. J. Pharm. Biomed. Anal., 2003, 33, 947-954.
70. Mendez, A.S.; Dalomo, J.; Steppe M.; Schapoval, E.E. Stability and degradation kinetics of meropenem in powder for injection and reconstituted samples. J. Pharm. Biomed. Anal., 2006, 41, 1363-1366.
71. Takeuchi, Y.; Sungawa, M.; Isobe, Y.; Hamazume, Y.; Noguchi, T. Stability of a 1-beta-methylcarbapenem antibiotic, meropenem in aqueous solution. Chem. Pharm. Bull., 1994, 43, 659-692.
72. Takeuchi, Y.; Takebayashi, Y.; Sunagawa, M.; Isobe, Y.; Hamazume, Y.; Uemura, A.; Noguchi, T. The stability of a novel carbapenem antibiotic, Meropenem (SM-7338), in a solid state formulation for injection. Chem. Pharm. Bull., 1993, 41, 1998-2002.
73. Mendez, A.; Chagastelles, P.; Palma, E.; Nardi, N.; Schapoval, E. Thermal and alkaline stability of meropenem: Degradation products and cytotoxicity. Inter. J. Pharm., 2008, 350, 95-102.
74. Patel, R.P.; Cook, S.E. Stability of meropenem in intravenous solutions. Am. J. Health Syst. Pharm., 1997, 54, 412-421.
75. Grant, E.; Zhong, M.; Ambrose, P.; Nicolau, D.; Nightingale, Ch.; Quintilliani, R. Stability of meropenem in a portable infusion device in a cold pouch. Am. J. Health Syst. Pharm., 2000, 57, 992-995.
76. Jaruratanasirikul, S.; Sriwiriyajan, S. Stability of meropenem in normal saline solution after storage at room temperature. Southeast Asian J. Trop. Med. Pub. Health, 2003, 34, 627-629.
77. Elragehy, N.A.; Abdel-Moety, E.M.; Hassan, N.Y.; Rezk, M.R. Stability-indicating determination of meropenem in presence of its degradation product. Talanta, 2008, 77, 28-36.
78. Cai, S.Y.; Hu, Ch. Chromatographic determination of polymerized impurities in meropenem. J. Pharm. Biomed. Anal., 2005, 37, 585-589.
79. Kramer, I. Stability of meropenem in elastomeric portable infusion devices. EHP, 1997, 3, 168-171.
80. Smith, D.L.; Bauer, S.M.; Nicolau, D.P. Stability of meropenem in polyvinyl chloride bags and an elastometric infusion device. Am. J Health-Syst Pharm., 2004, 61, 1682-1985.
81. Berthoin, K.; Duff, C.S.; Marchand-Brynaert, J.; Carryn, S.; Tulkens, P.M. Stability of meropenem and doripenem solutions for administration by continuous infusion. J. Antimicrob. Chemother., 2010, 65(5), 1073-1075.
82. Keel, R.; Christina, A.; Sutherland, J.; Crandon, M.; Nicolau, D. Stability of doripenem, imipenem and meropenem at evaluated room temperatures. Int. J. Antimicrob. Agents., 2010, doi:10.1016/j.ijantimicag.2010.06.043; [E-pub ahead of print].
83. Cielecka-Piontek, J.; Zajac, M.; Jelińska, A. A comparison of the stability of ertapenem and meropenem in pharmaceutical preparations in solid state. J. Pharm. Biomed. Anal., 2008, 46, 52-57.
84. Kitahashi, T.; Furuta, I. Determination of meropenem by capillary electrophoresis using direct injection of serum. J. Chromatogr. Sci., 2005, 43, 430-433.
85. Chou, Y.; Yang, Y.; Chen, J.; Kuo, Ch.; Chen, S. Quantification of meropenem in plasma and cerebrospinal fluid by micellarelectrokinetic capillary chromatography and application in bacterial meningitis patients. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2007, 856, 294-301.
86. Mrestani, Y.; Neubert, R.; Nagel, F. Capillary zone electrophoresis determination of meropenem in biological media using a high sensitivity cell. J. Pharm. Biomed. Anal., 1999, 20, 899-903.
87. Igarashi, J.; Nishimura, T.; Sasaki, A.; Sungawa, M. Conformational analysis of meropenem and desmethyl meropenem: the effect of β-methyl group on carbapenem antibiotics. Bioorg. Med. Chem., 1996, 6, 1881-1886.
88. Yanagi, K.; Takeuchi, Y.; Sunagawa, M. Structure of a novel carbapenem antibiotic, meropenem. Acta Cryst., 1992, 48, 1737-1739.
89. Mendez, A.; Weisheimer, V.; Oppe, T.; Steppe, M.; Schapoval, E. Microbiological assay for the determination of meropenem in pharmaceutical dosage form. J. Pharm. Biomed. Anal., 2005, 37, 649-653.
90. Hammond, M. Ertapenem: a group 1 carbapenem with distinct antibacterial and pharmacological properties. J. Antimicrob. Chemother., 2004, Suppl. S2, ii7-ii9.
91. Crocker, L.; Wang, Y.; McCauley, A. Determination of the optimum pH for isolation of a compound with multiple pKa's from aqueous-organic solvent mixtures. Org. Proc. Res. Develop., 2001, 5, 77-79.
92. Musson, D.; Majumdar, A.; Birk, K.; Holland, Sh.; Wickersham, P.; Li, S.; Mistry, G.; Fisher, A.; Waldman, S.; Greenberg, H.; Deutsch, P.; Rogers, J. Pharmacokinetics of intramuscularly administered ertapenem. Antimicrob. Agents Chemother., 2003, 47, 1732-1735.
93. Musson, D.; Birk, K.; Cairns, A.; Majumdar, A.; Rogers, J. Highperformance liquid chromatographic methods for the determination of a new carbapenem antibiotics. L-749,345, in human plasma and urine. J. Chromatogr. B., 1998, 720, 99-106.
94. Majumdar, A.; Musson, D.; Birk, K.; Kitchen, C.; Holland, S.; McCrea, J.; Mistry, G.; Hensney, M.; Xi, L.; Li, S.; Haesen, R.; Blum, R.; Lins, R.; Greenberg, H.; Waldman, S.; Deutsch, P.; Rogers, J. Pharmacokinetics of ertpanenem in healthy young volunteers. Antimicrob. Agents Chemother., 2002, 46, 3506-3511.
95. Musson, D.; Majumdar, A.; Birk, K.; Holland, Sh.; Wickersham, P.; Li, S.; Mistry, G.; Fisher, A.; Waldman, S.; Greenberg, H.; Deutsch, P.; Rogers, J. Pharmacokinetics of intramuscularly administered ertapenem. Antimicrob. Agents Chemother., 2003, 47, 1732-1735.
96. Musson, D.; Birk, K.; Kitchen, Ch.; Zhang, J.; Hsieh, J.; Fang, W.; Majumdar, A.; Rogers, J.; Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotics, in human plasma. J. Chromatogr. B., 2003, 783, 1-9.
97. Gordien, J.; Boselli, E.; Fleureau, C.; Allaouchiche, B.; Janvier, G.; Lalaude, O.; Saux, M.; Breilh, D. Determination of free ertapenem in plasma and bronchoalveolar lavage by high-perfromance liquid chromatography with ultraviolet detection. J. Chromatogr. B., 2006, 830, 218-223.
98. Musson, D.; Kitchen, Ch.; Hsieh, J.; Birk, K. Modified highperformance liquid chromatographic method for the determination of ertapenem in human urine: enhanced selectivity and automation. J. Chromatogr. B., 2002, 779, 341-346.
99. Kitchen, Ch.; Musson, D.; Fisher, A. Column-switching technique for the sensitive determination of ertapenem in human cerebrospinal fluid using liquid chromatography and ultraviolet absorbance detection. J. Chromatogr. B., 2004, 799, 9-14.
100. Xuan, D.; Banevicius, M.; Capitano, B.; Kim, M.; Nightingale, Ch.; Nicolau, D. Pharmacodynamic assessment of ertapenem (MK-0826) against Streptococcus pneumonia in a murine nuetropenic thigh infection model. Antimicrob. Agents Chemother., 2002, 46, 2990-2995.
101. Nix, D.; Matthias, K.; Ferguson, E. Effect of ertapenem protein binding on killing of bacteria. Antimicrob. Agents Chemother., 2004, 48, 3419-3424.
102. Koal, T.; Deters, M.; Resch, K.; Kaever, V. Quantfication of the ertapenem antibiotics ertapenem in human plasma by a validated liquid chromatography-mass spectrometry method. Clin. Chim. Acta., 2006, 364, 239-245.
103. Mundkowski, R.; Majcher-Peszynska, J.; Burkhardt, O.; Welte, T.; Drewelow, B. A new simple HPLC assay for quantification of ertapenem in human plasma, lung tissue, and broncho-alveolar lavage fluid. J. Chromatogr. B., 2006, 832, 213-235.
104. Lefeuvre, S.; Venisse, N.; Marchand, S.; Bachelet, M.; Couet, W. A simple and sensitive liquid chromatography-tandem mass spectrometry assay for the quantification or ertapenem in microdialysate. J. Chromatogr. B., 2008, 862, 242-245.
105. Sajonz, P.; Natishan, T.; Wu, Y.; McGachy, N.; DeTora, D. Development and validation of a sensitive and robust wipe-test method for the detection and quantification of the antibiotic ertapenem and its primary degradates in a pharmaceutical manufacturing environment. J. Liq. Chromatogr. Relat. Technol., 2005, 28, 713-725.
106. Vailaaya, A.; Sajonz, P.; Sudah, S.; Capodanno, V.; Helmy, R.; Antia, F. Exploiting pH mismatch in preparative high-performance liquid chromagraphic recovery of ertapenem from mother liquor streams. J. Chromatogr. A, 2005, 1079, 8-91.
107. Sajonz, P.; Natishan, T.; Wu, Y.; Williams, J.; Pipik, B.; DiMichele, L.; Novak, T.; Pitzenberger, Dubost, D.; Almarsson, O. Preparation, isolation, and characterization of dimeric degradation products of the 1β-methylcarbapenem antibiotics, ertapenem. J. Liq. Chromatogr. Relat. Technol., 2001, 24, 2999-3015.
108. Zajac, M.; Cielecka-Piontek, J.; Jelińska, A. Stability of ertapenem in aqueous solutions, J. Pharm. Biomed. Anal., 2007, 43, 445-449.
109. McQuade, M.; Nostrand, V.; Schariter, J.; Kanike, J.; Forsyth, R. Stability and compatibility of reconstituted ertapenem with commonly used i.v. infusion and coinfusion solutions. Am. J. Health- Syst. Pharm., 2004, 61, 38-45.
110. Zhao, Z.; Qin, X.; Reed, R. Identification by LC/MSn of degradates of a novel carbapenem antibiotics in an aqueous matrix. J. Pharm. Biomed. Anal., 2002, 29, 173-181.
111. Michalska, K.; Pajchel, G.; Tyski, S. Different sample stacking strategies for the determination of ertapenem and its impurities by micellarelectrokinetic chromatography in pharmaceutical formulation. J. Chromatogr. A., 2009, 1216, 2934-2942.
112. Hassan, N.; Abdel-Moety, E.; Elragehy, N.; Rezk, M. Selective determination of ertapenem in the presence of its degradation product. Spectrochimica Acta Part A., 2009, 72, 915-921.
113. Ikeda, K.; Ikawa, K.; Ikeda, A.; Nishikawa, Y.; Morikawa, N. A Simple and rapid determination of biapenem in plasma by highperformance liquid chromatography. J. Chromatogr. B., 2006, 844, 148-152.
114. Ikawa, K.; Morikawa, N.; Ikeda, K.; Sakashita, M.; Ohge, H.; Sueda, T. Penetrability of intravenous biapenem into the peritoneal fluid of laparotomy patients and the peritoneal pharmacodynamics against gram-negative bacteria. J. App. Res., 2009, 9, 107-112.
115. Kozawa, O.; Uematsu, T.; Matsuno, H.; Niwa, M.; Takiguchi, Y.; Matsumoto, S.; Minamoto, M.; Nida, Y.; Yokokawa, M.; Nagashima, S.; Kanamaru, M. Pharmcokietics and safety of a new parenteral carbapenemantiobiotic, biapenem (L-627), in elderly subjects. Antimicrob. Agents Chemother., 1998, 42, 1433-1436.
116. Nagashima, S.; Kozawa, O.; Otsuka, T.; Kohno, K.; Minamoto, M.; Yokokawa, M.; Kanamaru, M.; Uematsu, T. Phamracokinetics of a parenteral carbapenem, biapenem, in patients with end-stage renal disease and influence of haemodialysis. J. Antimicrob. Chemother., 2000, 46, 839-842.
117. Kameda, K.; Ikawa, K.; Ikeda, K.; Morikawa, N.; Nakashima, A.; Ohge, H.; Sueda, T. HPLC method for measuring meropenem and biapenem concentrations in human peritoneal fluid and bile: application to comparative pharmacokinetic investigations. J. Chromatogr. Sci., 2010, 48, 406-411.
118. Xia, M.; Hang, T.; Zhang, F.; Li, X.; Xu, X. The stability of biapenem and structural identification of impurities in aqueous solution. J. Pharm. Biomed. Anal., 2009, 49, 937-944.
119. Cielecka-Piontek, J.; Jeliaska, A.; Dołhań, A.; Nasreen, A.; Shampa, I. Kinetic and thermodynamic analysis of degradation of doripenem in solid state. Conference "Progress in the evaluation of quality of pharmaceutical substances" Poznan, Poland 2010, 17-18 July, 80.
120. Cielecka-Piontek, J.; Lunzer, A.; Jelińska, A. Stability-indicating derivative spectrophotometry method for the determination of biapenem in the presence of its degradation products. Cent. Eur. J. Chem., 2011, 9, 35-40.
121. Anderson, D. Doripenem. Drugs Today, 2006, 42, 399-404.
122. Ikeda, K.; Ikawa, K.; Morikawa, N.; Kameda, K.; Urakawa, N.; Ohge, H.; Sueda, T. Quantification of doripenem in human plasma nad peritoneal fluid by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B., 2008, 867, 20-25.
123. Ikawa, K.; Morikawa, N.; Urakawa, N, Ikeda, K.; Ohge, H.; Sueda, T. Peritoneal penetration of doripenem after intravenous administration in abdominal-surgery patients. J. Antimicrob. Chemother., 2007, 60, 1395-1397.
124. Yamada, Y.; Ikawa, K.; Nakamura, K.; Mitsui, K.; Narushima, M.; Hibi, H.; Ikeda, K.; Morikawa, N.; Honda, N. Penetration of doripenem into prostatic tissue following intravenous administration in prostatectomy patients. Int. J. Antimicrob. Agents, 2010, 35, 504-506.
125. Sutherland, Ch.; Nicolau, D. Development of an HPLC method for the determination of doripenem in human and mouse serum. J. Chrom. B., 2007, 853, 123-126.
126. Louie, A.; Bied, A.; Fregeau, Ch.; Scoy, B.; Brown, D.; Liu, W.; Bush, K.; Queenan, A.; Morrow, B.; Khashab, M.; Kahn, J.; Nicholson, S.; Kulawy, R.; Drusano G. Impact of different carbapenems and regimens of administration resistance emergence for three isogenic Pseudomonas aeruginosa strains with differing mechanisms of resistance. J. Antimicrob. Chemother., 2010, 54, 2638-2645.
127. Hidaka, S.; Goto, K.; Hagiwara, S.; Iwasaka, H.; Noguchi, T. Doripenempharmacokientics in critically III patients receiving continuous hemodiafiltration. YakugakuZasshi, 2010, 130, 87-94.
128. Crandon, J.; Sutherland, Ch.; Nicolau, D. Stability of doripenem in polyvinyl chloride bags and elastomeric pumps. Am. J. Health-Syst. Pharm., 2010, 15, 1539-1544.
129. Psathas, P.; Kuzmission, A.; Ikeda, K.; Yasuo, S. Stability of doripenem in vitro in representative infusion solutions and infusion bags. Clin. Therap., 2008, 30, 2075-2087.
130. Cielecka-Piontek, J.; Jeliaska, A. Catalytic effect of buffers on the degradation of doripenem in aqueous solutions. Reac. Kinet. Mech. Cat., 2011, 102, 37-47.
131. Cielecka-Piontek, J.; Krause, A.; Milewski, M.; Lunzer, A.; Jelińska, A.; Zalewski, P. Stability-indicating LC method for the determination of biapenem in the presence of degradation products, 36th International Symposium High-Performance Liquid Phase Separations and Related Techniques, 19-23 June 2011, Hungary, P2-G-735-WE.
132. Cielecka-Piontek, J.; Jelińska, A. The UV-derivative spectrophotometry for the determination of doripenem in the presence of its degradation products. Spectrochimica Acta Part A., 2010, 77, 554-557.
133. Michalska, K.; Pajchel, G.; Tyski, S. Determination of doripenem and related subsntances in medicinal product using capillary electrophoresis. J. Sep. Sci., 2011, 34, 1-8.
134. Legrand, T.; Chun, S.; Rey, E.; Blanchet, B.; Zahar, J.; Lanternier, F.; Pons, G.; Jullien, V. Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection. J. Chromatogr. B., 2008, 875, 551-556.
135. Kurihara, Y.; Kizu, J.; Hori, S. Simple and rapid determination of serum carbapenem concentration by high-performance liquid chromatography. J. Infect. Chemother., 2008, 14, 30-34.
136. Aparicio, I.; Bello, M.; Callejon, M.; Jimenez, J. Liquid chromatographic method for the simultaneous determination of imipenem and sulbactam in mouse plasma. J. Chromatogr. Sc., 2006, 44, 548-551.
137. Ehrlich, M.; Daschner, F.; Kummerer, K. Rapid antibiotic drug monitoring: meropenem and ceftazidime determination in serum and bronchial secretions by high-performance liquid chromatography- integrated sample preparation. J. Chromatogr. B., 2001, 751, 357-363.
138. Spell, J.; Stewart, J. HPLC analysis of a meropenem-ofloxacin mixture in intravenous solutions using a nonporous octadecylsilane column. J. Liq. Chrom. Relat. Technol., 1999, 22, 2225-2234.
139. Frenandez-Torres, R.; Bello-Lopez, M.; Callejon-Mochon, M.; Jimenez-Sanchez, J. Determination of imipenem and rifampicin in mouse plasma by high performance liquid chromatography-diode array detection. Anal. Chim. Acta, 2008, 608, 204-210.
140. Taniguchi, S.; Hamase, K.; Kinoshita, A.; Zaitsu, K. Simple and rapid analytical method for carbapenems using capillary zone electrophoresis. J. Chromatogr. B., 1999, 727, 219-225.
141. Zajac, M.; Cielecka-Piontek, J.; Jelińska, A. Development and validation of UV spectrophotometric and RP.HPLC methods for determination of ertapenemduring stability studies. Chem. Anal., 2006, 51, 761-768.
142. Lopez, K.; Bertoluci, D.; Vicente, K.; Aquilla, A.; Santos, S. Simultaneous determination of cefepime, vancomycin and imipenem in human plasma of burn patients by high-performance liquid chromatography. J. Chromatogr. B, 2007, 860, 241-245.
143. Denooz, R.; Charlier, C. Simultaneous determination of five β-lactam antibitcs (cefepim, ceftazidim, cefuroxim, meropenem and piperacillin) in human plasma bu high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B, 2008, 864, 161-167.
144. Baranowska, I.; Markowski, P.; Baranowski, J. Simultaneous determination of 11 drugs belonging to four different groups in human urine samples by reversed high-performance liquid chromatography method. Anal. Chim. Acta, 2006, 570, 46-58.
145. Caufield, W.; Stewart, J. HPLC separations of meropenem and selected pharmaceuticals using polar endcappedoctadecylsilane narrow bore column. Chromatographia, 2000, 51, 308-314.
146. Pletz, M.; Rau, M.; Bulitta, J.; De Roux, A.; Burkhardt, O.; Kruse, G.; Kurowski, M.; Nord, C.; Lode, H. Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers. Antimicrob. Agents Chemother., 2004, 48, 3765-3772.
147. El-Shaboury, S.R.; Saleh, G.A.; Mohamed, F.A.; Rageh, A.H. Analysis of cephalosporin antibiotics. J. Pharm. Biomed. Anal., 2007, 45, 1-19.
148. Garcia-Ruiz, C.; Marina, M.L. Recent advances in the analysis of antibiotics by capillary electrophoresis. Electrophoresis, 2006, 27(1), 266-282.
149. Castro-Puyana, M.; Crego, A.L.; Marina, M.L. Recent advances in the analysis of antibiotics by CE and CEC. Electrophoresis, 2008, 29, 274-293.
150. Castro-Puyana, M.; Crego, A.L.; Marina, M.L. Recent advances in the analysis of antibiotics by CE and CEC. Electrophoresis, 2010, 31, 229-250.
151. Cielecka-Piontek, J.; Michalska, K.; Zalewski, P.; Jelińska, A. Recent Advances in Stability Studies of Carbapenems. Curr. Pharm. Anal., 2011, 7, 213-227.